Priser
Platform
Blog
Om os
Download
MATD3
Hospital Mater Dei
0

Om

Hospital Mater Dei S.A. is a leading healthcare provider in Brazil, specializing in delivering a comprehensive range of medical services. Recognized for its state-of-the-art facilities and patient-focused approach, the company operates advanced hospitals that focus on critical care, elective procedures, and various specialized treatments. The company's extensive network caters to the demands of multiple patient demographics, maintaining a strong presence in the healthcare sector by upholding high standards of medical care and innovation.

Hospital Mater Dei S.A. plays a pivotal role in Brazil's healthcare market by addressing the critical needs of the population through its multidisciplinary team of professionals. Its focus on quality care and technological advancement positions it as a reliable choice for patients and makes it an integral part of the local healthcare infrastructure. Through its commitment to excellence, Hospital Mater Dei S.A. continues to influence health outcomes positively and contributes significantly to the overall improvement of public health standards in the regions it serves.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I HOSPITAL MATER DEI MED ENDAVU: Køb Hospital Mater Dei ($MATD3) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Hospital Mater Dei, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

TickerMATD3
Land
Brasilien
Hjemmesidematerdei.com.br
SektorSundhed
IndustriMedicinske plejefaciliteter

Udbytter

0,06BRL
'23
0,07BRL
'24
0,23BRL
'25
Ex-udbytte-dato9. dec. 2025
Udbytteafkast2,6%